Advanced search
Publication Cover
Gut Microbes Volume 13, 2021 - Issue 1
Submit an article Journal homepage
7,636
Views
26
CrossRef citations to date
0
Altmetric
Research Paper

Links between gut microbiome composition and fatty liver disease in a large population sample

Matti O. Ruuskanena Department of Internal Medicine, University of Turku, Turku, Finland;b Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, FinlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4221-2880View further author information
ORCID Icon,
Fredrik Åbergc Transplantation and Liver Surgery Clinic, Helsinki University Hospital, University of Helsinki, Helsinki, Finland;d Transplant Institute, Sahlgrenska University Hospital, Gothenburg, SwedenORCID Iconhttps://orcid.org/0000-0002-3833-0705View further author information
ORCID Icon,
Ville Männistöe Department of Medicine, Kuopio University Hospital, University of Eastern Finland, Kuopio, Finland;f Department of Experimental Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsORCID Iconhttps://orcid.org/0000-0002-0735-400XView further author information
ORCID Icon,
Aki S. Havulinnab Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland;g Institute for Molecular Medicine Finland, FIMM - HiLIFE, Helsinki, FinlandORCID Iconhttps://orcid.org/0000-0002-4787-8959View further author information
ORCID Icon,
Guillaume Mérich Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia;i Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria, AustraliaORCID Iconhttps://orcid.org/0000-0001-6288-9958View further author information
ORCID Icon,
Yang Liuh Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia;j Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, AustraliaView further author information
,
Rohit Loombak Department of Medicine, NAFLD Research Center, La Jolla, CA, USA;l Department of Medicine, University of California San Diego, La Jolla, CA, USAORCID Iconhttps://orcid.org/0000-0002-4845-9991View further author information
ORCID Icon,
Yoshiki Vázquez-Baezam Center for Microbiome Innovation, Jacobs School of Engineering, University of California San Diego, La Jolla, CA, USAORCID Iconhttps://orcid.org/0000-0001-6014-2009View further author information
ORCID Icon,
Anupriya Tripathin Collaborative Mass Spectrometry Innovation Center, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA;o Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA;p Division of Biological Sciences, University of California San Diego, La Jolla, CA, USAORCID Iconhttps://orcid.org/0000-0001-8912-9684View further author information
ORCID Icon,
Liisa M. Valstab Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, FinlandView further author information
,
Michael Inouyeh Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia;q Department of Public Health and Primary Care, Cambridge University, Cambridge, UKORCID Iconhttps://orcid.org/0000-0001-9413-6520View further author information
ORCID Icon,
Pekka Jousilahtib Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, FinlandView further author information
,
Veikko Salomaab Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, FinlandORCID Iconhttps://orcid.org/0000-0001-7563-5324View further author information
ORCID Icon,
Mohit Jainl Department of Medicine, University of California San Diego, La Jolla, CA, USA;r Department of Pharmacology, University of California San Diego, La Jolla, California, USAORCID Iconhttps://orcid.org/0000-0001-8628-2069View further author information
ORCID Icon,
Rob Knightm Center for Microbiome Innovation, Jacobs School of Engineering, University of California San Diego, La Jolla, CA, USA;s Department of Pediatrics, School of Medicine, University of California San Diego, La Jolla, California, USA;t Department of Computer Science & Engineering, University of California San Diego, La Jolla, California, USAORCID Iconhttps://orcid.org/0000-0002-0975-9019View further author information
ORCID Icon,
Leo Lahtiu Deparment of Computing, University of Turku, Turku, FinlandORCID Iconhttps://orcid.org/0000-0001-5537-637XView further author information
ORCID Icon &
Teemu J. Niiranena Department of Internal Medicine, University of Turku, Turku, Finland;b Department of Public Health Solutions, Finnish Institute for Health and Welfare, Helsinki, Finland;v Division of Medicine, Turku University Hospital, Turku, FinlandORCID Iconhttps://orcid.org/0000-0002-7394-7487View further author information
ORCID Icon show all
Article: 1888673 | Received 17 Aug 2020, Accepted 28 Jan 2021, Published online: 02 Mar 2021

References

  • Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–22. doi:10.1002/hep.28431.
  • Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917–923. doi:10.1053/jhep.2003.50161.
  • Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–2023. doi:10.1002/hep.25762.
  • Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014;2(11):901–910. doi:10.1016/S2213-8587(14)70032-4.
  • Toshikuni N. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(26):8393–8406. doi:10.3748/wjg.v20.i26.8393.
  • Rinella M, Charlton M. The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health. Hepatology. 2016;64(1):19–22. doi:10.1002/hep.28524.
  • Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med. 2018;24(4):392–400. doi:10.1038/nm.4517.
  • Caussy C, Tripathi A, Humphrey G, Bassirian S, Singh S, Faulkner C, Bettencourt R, Rizo E, Richards L, Xu ZZ, et al. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat Commun. 2019;10(1):1406. doi:10.1038/s41467-019-09455-9.
  • Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Cartenì M, Nardone G. Gut–liver axis: the impact of gut microbiota on non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2012;22(6):471–476. doi:10.1016/j.numecd.2012.02.007.
  • Miele L, Valenza V, Torre GL, Montalto M, Cammarota G, Ricci R, Mascianà R, Forgione A, Gabrieli ML, Perotti G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49(6):1877–1887. doi:10.1002/hep.22848.
  • Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 2011;140(3):976–986. doi:10.1053/j.gastro.2010.11.049.
  • Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57(2):601–609. doi:10.1002/hep.26093.
  • Yuan J, Chen C, Cui J, Lu J, Yan C, Wei X, Zhao X, Li N, Li S, Xue G, et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab. 2019;30(4):675–688.e7. doi:10.1016/j.cmet.2019.08.018.
  • Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK, et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 2017;25(5):1054–1062.e5. doi:10.1016/j.cmet.2017.04.001.
  • Jiao N, Wu D, Yang Z, Fang S, Li X, Yuan M, Zhu R, Zhu L. Gut bacteria contributes to NAFLD pathogenesis by promoting secondary bile acids biosynthesis. The FASEB Journal. 2019;33:4–126
  • Aron-Wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, Nieuwdorp M, Clément K. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol. 2020;17(5):279–297. doi:10.1038/s41575-020-0269-9.
  • Qin N, Yang F, Li A, Prifti E, Chen Y, Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513(7516):59–64. doi:10.1038/nature13568.
  • Liu Y, Meric G, Havulinna AS, Teo SM, Ruuskanen M, Sanders J, Zhu Q, Tripathi A, Verspoor K, Cheng S, et al. Early prediction of liver disease using conventional risk factors and gut microbiome-augmented gradient boosting [Internet]. Genet Genomic Med. 2020;06(24). [cited 2020 Jul 28]. Available from https://www.medrxiv.org/content/10.1101/2020.06.24.20138933v1. doi:10.1101/2020.06.24.20138933.
  • Safari Z, Gérard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci. 2019;76(8):1541–1558. doi:10.1007/s00018-019-03011-w.
  • Carpino G, Del Ben M, Pastori D, Carnevale R, Baratta F, Overi D, Francis H, Cardinale V, Onori P, Safarikia S, et al. Increased liver localization of lipopolysaccharides in human and experimental NAFLD. Hepatology. 2019;72(2):470–485. doi:10.1002/hep.31056.
  • Li Q, Dhyani M, Grajo JR, Sirlin C, Samir AE. Current status of imaging in nonalcoholic fatty liver disease. World J Hepatol. 2018;10(8):530–542. doi:10.4254/wjh.v10.i8.530.
  • Koehler EM, Schouten JNL, Hansen BE, Hofman A, Stricker BH, Janssen HLA. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201–1204. doi:10.1016/j.cgh.2012.12.031.
  • Vanni E, Bugianesi E. Editorial: utility and pitfalls of fatty liver index in epidemiologic studies for the diagnosis of NAFLD. Aliment Pharmacol Ther. 2015;41(4):406–407. doi:10.1111/apt.13063.
  • Salosensaari A, Laitinen V, Havulinna AS, Meric G, Cheng S, Perola M, Valsta L, Alfthan G, Inouye M, Watrous JD, et al. Taxonomic signatures of long-term mortality risk in human gut microbiota [Internet]. Epidemiology. 2020;12(30): [cited 2020 Jan 4]. Available from https://www.medrxiv.org/content/10.1101/2019.12.30.19015842v2. doi:10.1101/2019.12.30.19015842
  • Alexander M, Loomis AK, Fairburn-Beech J, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease. BMC Med. 2018;16(1):130. doi:10.1186/s12916-018-1103-x.
  • Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6(1):33. doi:10.1186/1471-230X-6-33.
  • Hillmann B, Al-Ghalith GA, Shields-Cutler RR, Zhu Q, Gohl DM, Beckman KB, Knight R, Knights D. Evaluating the information content of shallow shotgun metagenomics. mSystems [Internet]. 2018; 3.cited 2020 Apr 9 Available from https://msystems.asm.org/content/3/6/e00069–18
  • Parks DH, Chuvochina M, Waite DW, Rinke C, Skarshewski A, Chaumeil P-A, Hugenholtz P. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat Biotechnol. 2018;36(10):996–1004. doi:10.1038/nbt.4229.
  • Silverman JD, Washburne AD, Mukherjee S, David LA. A phylogenetic transform enhances analysis of compositional microbiota data. eLife. 2017;6:e21887. doi:10.7554/eLife.21887.
  • Borodulin K, Tolonen H, Jousilahti P, Jula A, Juolevi A, Koskinen S, Kuulasmaa K, Laatikainen T, Männistö S, Peltonen M, et al. Cohort profile: the National FINRISK study. Int J Epidemiol. 2018;47(3):696. i. doi:10.1093/ije/dyx239.
  • Banderas DZ, Escobedo J, Gonzalez E, Liceaga MG, Ramírez JC, Castro MG. γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. Eur J Gastroenterol Hepatol. 2012;24(7):805–810. doi:10.1097/MEG.0b013e328354044a.
  • Haas JT, Francque S, Staels B. Pathophysiology and mechanisms of nonalcoholic fatty liver disease. Annu Rev Physiol. 2016;78(1):181–205. doi:10.1146/annurev-physiol-021115-105331.
  • Castaner O, Goday A, Park Y-M, Lee S-H, Magkos F, Shiow S-ATE, Schröder H. The gut microbiome profile in obesity: a systematic review. Int J Endocrinol. 2018; 2018:4095789. doi:10.1155/2018/4095789.
  • Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C, Kleiner DE, Brunt E, Bugianesi E, Yki-Järvinen H, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.e1. doi:10.1053/j.gastro.2019.11.312.
  • He Y, Wu W, Zheng H-M, Li P, McDonald D, Sheng H-F, Chen M-X, Chen Z-H, Ji G-Y, Zheng ZDX, et al. Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nat Med. 2018;24(10):1532–1535. doi:10.1038/s41591-018-0164-x.
  • Carvalhana S, Leitão J, Alves AC, Bourbon M, Cortez-Pinto H. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound. Liver Int. 2014;34(6):e111–7. doi:10.1111/liv.12305.
  • Leathers JS, Balderramo D, Prieto J, Diehl F, Gonzalez-Ballerga E, Ferreiro MR, Carrera E, Barreyro F, Diaz-Ferrer J, Singh D. PIB: a score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings. Hepat Mon. 2018;18(10):18. doi:10.5812/hepatmon.82345.
  • Yang B-L, Wu W-C, Fang K-C, Wang Y-C, Huo T-I, Huang Y-H, Yang H-I, Su C-W, Lin H-C, Lee F-Y, et al. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PLos One. 2015;10(3):e0120443. doi:10.1371/journal.pone.0120443.
  • Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, Ding L, Lin L, Xu Y, Chen Y, et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore). 2015;94(40):e1682. doi:10.1097/MD.0000000000001682.
  • Astbury S, Atallah E, Vijay A, Aithal GP, Grove JI, Valdes AM. Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes. 2020;11(3):569–580. doi:10.1080/19490976.2019.1681861.
  • Kim H-N, Joo E-J, Cheong HS, Kim Y, Kim H-L, Shin H, Chang Y, Ryu RS. Gut microbiota and risk of persistent nonalcoholic fatty liver diseases. J Clin Med. 2019;8(8):1089. doi:10.3390/jcm8081089.
  • de la Cuesta-zuluaga J, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS. Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of Westernization. Sci Rep. 2018;8(1):11356. doi:10.1038/s41598-018-29687-x.
  • O’Callaghan A, van Sinderen D. Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol 2016;7:925. doi:10.3389/fmicb.2016.00925.
  • Waters JL, Ley RE. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biol. 2019;17(1):83. doi:10.1186/s12915-019-0699-4.
  • Ferreira-Halder CV, Faria de S AV, Andrade SS. Action and function of Faecalibacterium prausnitzii in health and disease. Best Pract Res Clin Gastroenterol. 2017;31(6):643–648. doi:10.1016/j.bpg.2017.09.011.
  • Liu G-L, Qingxi Q-Z, Hongyun H-W. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis. Ann Hepatol. 2019;18(6):796–803. doi:10.1016/j.aohep.2019.06.020.
  • Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013;11(7):e3. doi:10.1016/j.cgh.2013.02.015.
  • Dong TS, Katzka W, Lagishetty V, Luu K, Hauer M, Pisegna J, Jacobs JP. A microbial signature identifies advanced fibrosis in patients with chronic liver disease mainly due to NAFLD. Sci Rep. 2020;10(1):2771. doi:10.1038/s41598-020-59535-w.
  • Bajaj JS, Idilman R, Mabudian L, Hood M, Fagan A, Turan D, White MB, Karakaya F, Wang J, Atalay R, et al. Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort. Hepatology. 2018;68(1):234–247. doi:10.1002/hep.29791.
  • Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, Wood DLA, Gellatly SL, Shukla SD, Wood LG, et al. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun. 2020;11(1):5886. doi:10.1038/s41467-020-19701-0.
  • Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, et al. Human genetics shape the gut microbiome. Cell. 2014;159(4):789–799. doi:10.1016/j.cell.2014.09.053.
  • Suzuki TA, Worobey M. Geographical variation of human gut microbial composition. Biol Lett. 2014;10(2):20131037. doi:10.1098/rsbl.2013.1037.
  • Meslier V, Laiola M, Roager HM, Filippis FD, Roume H, Quinquis B, Giacco R, Mennella I, Ferracane R, Pons N, et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut [Internet] cited 2020 Jun 2]; Available from. 2020;69(7):1258–1268. doi:10.1136/gutjnl-2019-320438
  • Cui C, Li Y, Gao H, Zhang H, Han J, Zhang D, Li Y, Zhou J, Lu C, Su X. Modulation of the gut microbiota by the mixture of fish oil and krill oil in high-fat diet-induced obesity mice. PLos One. 2017;12(10):e0186216. doi:10.1371/journal.pone.0186216.
  • Manzoor SE, McNulty CAM, Nakiboneka-Ssenabulya D, Lecky DM, Hardy KJ, Hawkey PM. Investigation of community carriage rates of Clostridium difficile and Hungatella hathewayi in healthy volunteers from four regions of England. J Hosp Infect. 2017;97(2):153–155. doi:10.1016/j.jhin.2017.05.014.
  • Genoni A, Christophersen CT, Lo J, Coghlan M, Boyce MC, Bird AR, Lyons-Wall P, Devine DA. Long-term Paleolithic diet is associated with lower resistant starch intake, different gut microbiota composition and increased serum TMAO concentrations. Eur J Nutr. 2020;59(5):1845–1858. doi:10.1007/s00394-019-02036-y.
  • Burton KJ, Krüger R, Scherz V, Münger LH, Picone G, Vionnet N, Bertelli C, Greub G, Capozzi F, Vergères G. Trimethylamine-N-Oxide postprandial response in plasma and urine is lower after fermented compared to non-fermented dairy consumption in healthy adults. Nutrients. 2020;12(1):234. doi:10.3390/nu12010234.
  • Jiang W, Wu N, Wang X, Chi Y, Zhang Y, Qiu X, Hu Y, Li J, Liu Y. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci Rep. 2015;5(1):8096. doi:10.1038/srep08096.
  • Hillmann B, Al-Ghalith GA, Shields-Cutler RR, Zhu Q, Knight R, Knights D. SHOGUN: a modular, accurate and scalable framework for microbiome quantification. Bioinformatics. 2020;36(13):btaa277. doi:10.1093/bioinformatics/btaa277.
  • de Faria Ghetti F, Oliveira DG, de Oliveira JM, de Castro Ferreira LEVV, Cesar DE, Moreira APB. Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis. Eur J Nutr. 2018;57(3):861–876. doi:10.1007/s00394-017-1524-x.
  • Mohan R, Namsolleck P, Lawson PA, Osterhoff M, Collins MD, Alpert C-A, Blaut M. Clostridium asparagiforme sp. nov., isolated from a human faecal sample. Syst Appl Microbiol. 2006;29(4):292–299. doi:10.1016/j.syapm.2005.11.001.
  • Murray WD, Khan AW, van den BERG L. Clostridium saccharolyticum sp. nov., a saccharolytic species from sewage sludge. Int J Syst Bacteriol. 1982;32(1):132–135. doi:10.1099/00207713-32-1-132.
  • Diether NE, Willing BP. Microbial fermentation of dietary protein: an important factor in diet–microbe–host interaction. Microorganisms. 2019; 7(1)19: doi:10.3390/microorganisms7010019.
  • Zhao S, Jang C, Liu J, Uehara K, Gilbert M, Izzo L, Zeng X, Trefely S, Fernandez S, Carrer A, et al. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Nature. 2020;579(7800):586–591. doi:10.1038/s41586-020-2101-7.
  • Dehoux P, Marvaud JC, Abouelleil A, Earl AM, Lambert T, Dauga C. Comparative genomics of Clostridium bolteae and Clostridium clostridioforme reveals species-specific genomic properties and numerous putative antibiotic resistance determinants. BMC Genomics. 2016;17(1):819. doi:10.1186/s12864-016-3152-x.
  • Deschasaux M, Bouter KE, Prodan A, Levin E, Groen AK, Herrema H, Tremaroli V, Bakker GJ, Attaye I, Pinto-Sietsma S-J, et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med. 2018;24(10):1526–1531. doi:10.1038/s41591-018-0160-1.
  • Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15(5):261–273. doi:10.1038/s41574-019-0156-z.
  • Cheng H-Y, Wang H-Y, Chang W-H, Lin S-C, Chu C-H, Wang T-E, Liu -C-C, Shih S-C. Nonalcoholic fatty liver disease: prevalence, influence on age and sex, and relationship with metabolic syndrome and insulin resistance. Int J Gerontol. 2013;7(4):194–198. doi:10.1016/j.ijge.2013.03.008.
  • Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF, Suzuki A. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70(4):1457–1469. doi:10.1002/hep.30626.
  • Näyhä S. Geographical variations in cardiovascular mortality in Finland, 1961-1985. Scandinavian Journal of Social Medicine. Supplementum. 1989;40:1–48.
  • Kerminen S, Havulinna AS, Hellenthal G, Martin AR, Sarin A-P, Perola M, Palotie A, Salomaa V, Daly MJ, Ripatti S, et al. Fine-scale genetic structure in Finland. G3: Genes|Genomes|Genetics. 2017;7(10):3459–3468. doi:10.1534/g3.117.300217.
  • Reccia I, Kumar J, Akladios C, Virdis F, Pai M, Habib N, Spalding D. Non-alcoholic fatty liver disease: a sign of systemic disease. Metabolism. 2017;72:94–108.
  • Borodulin K, Vartiainen E, Peltonen M, Jousilahti P, Juolevi A, Laatikainen T, Männistö S, Salomaa V, Sundvall J, Puska P. Forty-year trends in cardiovascular risk factors in Finland. Eur J Public Health. 2015;25(3):539–546. doi:10.1093/eurpub/cku174.
  • Marotz L, Schwartz T, Thompson L, Humphrey G, Gogul G, Gaffney J, Amir A, Knight R Earth microbiome project (EMP) high throughput (HTP) DNA extraction protocol v1 (protocols.io.pdmdi46) [Internet]. 2018 [cited 2020 Nov 10]; Available from: https://www.protocols.io/view/earth-microbiome-project-emp-high-throughput-htp-d-pdmdi46
  • Sanders JG, Nurk S, Salido RA, Minich J, Xu ZZ, Zhu Q, Martino C, Fedarko M, Arthur TD, Chen F, et al. Optimizing sequencing protocols for leaderboard metagenomics by combining long and short reads. Genome Biol. 2019;20(1):226. doi:10.1186/s13059-019-1834-9.
  • Glenn TC, Nilsen RA, Kieran TJ, Sanders JG, Bayona-Vásquez NJ, Finger JW, Pierson TW, Bentley KE, Hoffberg SL, Louha S, et al. Adapterama I: universal stubs and primers for 384 unique dual-indexed or 147,456 combinatorially-indexed Illumina libraries (iTru & iNext). PeerJ. 2019;7:e7755. doi:10.7717/peerj.7755.
  • Didion JP, Martin M, Collins FS. Atropos: specific, sensitive, and speedy trimming of sequencing reads. PeerJ. 2017;5:e3720. doi:10.7717/peerj.3720.
  • Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9(4):357–359. doi:10.1038/nmeth.1923.
  • Méric G, Wick RR, Watts SC, Holt KE, Inouye M. Correcting index databases improves metagenomic studies. bioRxiv. 2019;712166. Available from https://www.biorxiv.org/content/10.1101/712166v1. doi:10.1101/712166.
  • Parks DH, Chuvochina M, Chaumeil P-A, Rinke C, Mussig AJ, Hugenholtz P. A complete domain-to-species taxonomy for bacteria and archaea. Nat Biotechnol. 2020;38(9):1079–86. doi:10.1038/s41587-020-0501-8.
  • Kim D, Song L, Breitwieser FP, Salzberg SL. Centrifuge: rapid and sensitive classification of metagenomic sequences. Genome Research. 2016 [cited 2018 May 12];26(12):1721–1729. doi:10.1101/gr.210641.116.
  • R Core Team. R: a language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2018 [cited 2019 Mar 4]. Available from: https://www.R-project.org/
  • McMurdie PJ, Holmes S, Watson M. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8(4):e61217. doi:10.1371/journal.pone.0061217.
  • Gloor GB, Macklaim JM, Pawlowsky-Glahn V, Egozcue JJ. Microbiome datasets are compositional: and this is not optional. Front Microbiol. 2017;8:2224. doi:10.3389/fmicb.2017.02224.
  • Louca S, Polz MF, Mazel F, Albright MBN, Huber JA, O’Connor MI, Ackermann M, Hahn AS, Srivastava DS, Crowe SA, et al. Function and functional redundancy in microbial systems. Nat Ecol Evol. 2018;2(6):936–943. doi:10.1038/s41559-018-0519-1.
  • Ruuskanen MO, St. Pierre KA, St. Louis VL, Aris-Brosou S, Poulain AJ. Physicochemical drivers of microbial community structure in sediments of lake hazen, Nunavut, Canada. Front Microbiol cited 2018 Jun 6]; 9. Available from. 2018;9:1138. doi:10.3389/fmicb.2018.01138
  • Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P, McGlinn D, Minchin PR, O’Hara RB, Simpson GL, Solymos P, et al. vegan: community ecology package [Internet]. 2018 [cited 2018 Jun 4]. Available from: https://CRAN.R-project.org/package=vegan
  • Lahti L, Shetty S. microbiome R package [Internet]. 2019 [cited 2020 Dec 14]. Available from: http://microbiome.github.io
  • Fernandes AD, Reid JN, Macklaim JM, McMurrough TA, Edgell DR, Gloor GB. Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis. Microbiome. 2014;2(1):15. doi:10.1186/2049-2618-2-15.
  • Chen T, Guestrin C. XGBoost: a scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining - KDD ’16; San Francisco (CA); 2016;785–794. https://dl.acm.org/doi/proceedings/10.1145/2939672.
  • Bommert A, Sun X, Bischl B, Rahnenführer J, Lang M. Benchmark for filter methods for feature selection in high-dimensional classification data. Comput Stat Data Anal. 2020;143:106839. doi:10.1016/j.csda.2019.106839.
  • Bischl B, Lang M, Kotthoff L, Schiffner J, Richter J, Studerus E, Casalicchio G, Jones ZM. mlr: machine learning in R. J Mach Learn Res. 2016;17:1–5.
  • Bischl B, Richter J, Bossek J, Horn D, Thomas J, Lang M. mlrMBO: a modular framework for model-based optimization of expensive black-box functions. arXiv:170303373 [stat] [Internet] 2018 [cited 2020 Feb 18]; Available from: http://arxiv.org/abs/1703.03373
  • Saito T, Rehmsmeier M. Precrec: fast and accurate precision–recall and ROC curve calculations in R. Bioinformatics. 2017;33(1):145–147. doi:10.1093/bioinformatics/btw570.
  • Greenwell BM. pdp: an R package for constructing partial dependence plots. R J. 2017;9(1):421–436. doi:10.32614/RJ-2017-016.
  • Yu G, Smith DK, Zhu H, Guan Y, Lam TTY, McInerny G. ggtree : an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol Evol. 2017;8(1):28–36. doi:10.1111/2041-210X.12628.
  • Douglas GM, Maffei VJ, Zaneveld J, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MGI. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685–688. doi:10.1038/s41587-020-0548-6
  • Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30(14):2068–2069. doi:10.1093/bioinformatics/btu153.
  • Belcour A, Frioux C, Aite M, Bretaudeau A, Hildebrand F, Siegel A. Metage2Metabo, microbiota-scale metabolic complementarity for the identification of key species. eLife. 2020;9:e61968. doi:10.7554/eLife.61968
  • Karp PD, Billington R, Caspi R, Fulcher A, Latendresse M, Kothari A, Keseler IM, Krummenacker M, Midford PE, Ong Q, et al. The BioCyc collection of microbial genomes and metabolic pathways. Brief Bioinform. 2019;20(4):bbz104. doi:10.1093/bib/bbx085.
  • Caspi R, Billington R, Fulcher CA, Keseler IM, Kothari A, Krummenacker M, Latendresse M, Midford PE, Ong Q, Ong WK, et al. The MetaCyc database of metabolic pathways and enzymes. Nucleic Acids Res. 2018;46(D1):D633–9. doi:10.1093/nar/gkx935.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.